Does Ozempic lower blood pressure?

4 min read

Written by: 

Leandra Beabout

Reviewed by: 

Austin Ulrich, PharmD, BCACP

Updated:  Nov 28, 2025

Trusted source badge

Reviewed By

Austin Ulrich, PharmD, BCACP

Austil Ulrich, PharmD, BCACP, is a board-certified ambulatory care pharmacist and freelance medical writer and reviewer. His experience includes direct patient care in hospitals and community pharmacies.

View bio

Key takeaways

  • Ozempic (semaglutide) is a medication for type 2 diabetes, but one of its possible side effects is lowering blood pressure (BP).

  • While not typically prescribed for BP specifically, research on semaglutide shows prolonged treatment at the highest dose can lower systolic BP by an average of 5 mmHg in people with hypertension (high blood pressure).

  • Ozempic may lower blood pressure by causing weight loss, improving insulin sensitivity, and relaxing blood vessels. 

  • Ozempic is not a quick fix for high blood pressure. However, lower blood pressure may be a positive long-term effect of Ozempic.

Here's what we'll cover

Here's what we'll cover

Key takeaways

  • Ozempic (semaglutide) is a medication for type 2 diabetes, but one of its possible side effects is lowering blood pressure (BP).

  • While not typically prescribed for BP specifically, research on semaglutide shows prolonged treatment at the highest dose can lower systolic BP by an average of 5 mmHg in people with hypertension (high blood pressure).

  • Ozempic may lower blood pressure by causing weight loss, improving insulin sensitivity, and relaxing blood vessels. 

  • Ozempic is not a quick fix for high blood pressure. However, lower blood pressure may be a positive long-term effect of Ozempic.

Ozempic (semaglutide) is usually prescribed to lower blood sugar, but it also has other effects, like weight loss and slowed progression of kidney disease. So, what about Ozempic and blood pressure (BP)? Can you take Ozempic with high blood pressure? Does Ozempic lower blood pressure? The short answer: Yes, Ozempic may actually improve your BP numbers. 

Keep reading for the details on Ozempic blood pressure benefits.

Does Ozempic lower blood pressure?

Yes, Ozempic can lower blood pressure, but the effect may be indirect. It’s not yet clear whether semaglutide directly lowers BP or if the improvement comes from other changes caused by Ozempic.

The weight loss and blood vessel-widening effects caused by semaglutide can absolutely result in “a modest drop in systolic blood pressure for some,” says Supriya Rao, MD, a quadruple board-certified physician in internal medicine, gastroenterology, obesity medicine, and lifestyle medicine.

Research on Ozempic and blood pressure

Before we look at the science, it’s important to understand that normal BP for most healthy adults is below 120/80 mmHg. The top number refers to systolic pressure (pressure on the arteries when the heart squeezes), while the bottom number refers to diastolic pressure (pressure on the arteries between heartbeats, when the heart is relaxed). Systolic pressure above 129 or diastolic pressure above 79 indicates hypertension (aka, high BP).

So, does Ozempic help with high blood pressure? Here’s what the science shows:

  • Semaglutide lowers systolic BP in people with hypertension. Research shows that it lowers systolic BP by about 5 mmHg in people with hypertension. While that’s not a major drop, it’s enough to reduce your risk of heart issues by about 10%.

  • Semaglutide results in lower BP than placebo. A 68-week study had participants taking 2.4 milligrams (mg) of semaglutide — the maximum Wegovy dose, which is higher than the maximum Ozempic dose. By the end of the study, their systolic BP readings were, on average, about 5 mmHg lower than those in the placebo group. Researchers noted that the drop in BP was likely due to weight loss caused by semaglutide.

  • Semaglutide lowers both systolic and diastolic BP. A 2023 review of six clinical trials found that semaglutide use resulted in systolic BP that was about 5 mmHg lower and diastolic BP that was about 2.5 mmHg lower than in placebo groups. 

  • Semaglutide lowers blood pressure more in some people than others. A 2025 meta-analysis found that semaglutide injections “significantly” reduced systolic and diastolic BP readings. It’s important to note that the blood-pressure-lowering effects were most significant in patients without diabetes and in those who used semaglutide long-term (for at least 50 weeks).

How does Ozempic lower blood pressure?

It’s not yet understood whether Ozempic directly lowers blood pressure. But Ozempic does have several effects on the body that can contribute to better cardiovascular health, including BP. 

Potential reasons why Ozempic lowers blood pressure include:

  • Weight loss

  • Improved insulin sensitivity

  • Blood vessel widening

Let’s dive into the details of how Ozempic may lower blood pressure.

Ozempic causes weight loss

Obesity and high blood pressure often go hand in hand. Up to 70% of hypertension cases may be linked to high body mass index (BMI). Ozempic can cause significant weight loss, which can lower BP in people with overweight or obesity.

Ozempic improves insulin sensitivity

The American Heart Association suggests that insulin resistance contributes to high BP. Ozempic, on the other hand, improves insulin sensitivity. Dr. Rao says this improvement “lightens the workload” on your blood vessels, reducing the force of blood as it pumps through your circulatory system (aka, your BP). 

Ozempic relaxes blood vessels 

Semaglutide is part of a drug class called glucagon-like peptide-1 receptor agonists (GLP-1s for short). These drugs have “vasodilatory effects,” meaning they relax and widen blood vessels. Dr. Rao explains that when your blood vessels are relaxed instead of rigid, you get better blood flow, which equals lower BP.

Can you get an Ozempic prescription for high blood pressure?

Ozempic is not an approved treatment for high BP, and you’re unlikely to find a healthcare provider who would prescribe it off-label for hypertension. “The average BP drop from semaglutide is modest,” Dr. Rao says. If you have hypertension, your provider is likely to prescribe a medication (or more than one) that will be more effective at lowering BP.

Dr. Rao says there are situations in which someone on Ozempic might eventually be able to lower their dosage or wean off their BP medication, but only with the guidance of a healthcare provider.

Check your coverage for FDA-approved GLP-1s—for free

Bottom line

Does Ozempic lower blood pressure? It can, but those effects are possibly indirect, only happen over the course of several months, and only in modest amounts. So, how does Ozempic help with high blood pressure? Here’s the recap.

  • Ozempic can lower systolic BP by about 5 mmHg. Results can vary from person to person and may depend on your baseline BP readings, your starting body weight, and how long you stay on Ozempic.

  • Weight loss can lower BP. Ozempic can cause weight loss, which can help lower BP in people with hypertension plus obesity or overweight. 

  • Better insulin sensitivity can lower BP. Ozempic helps the body release insulin, improving insulin sensitivity and potentially lowering BP.  

  • More relaxed blood vessels can lower BP. GLP-1s like Ozempic can help relax and widen blood vessels, which can improve BP.

  • Ozempic is not a cure for hypertension. “Treat Ozempic as a helper, not a replacement for lifestyle changes or prescribed BP drugs,” Dr. Rao says.

Frequently asked questions (FAQs)

DISCLAIMER

If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.

Ozempic Important Safety Information: Read more about serious warnings and safety info.

GLP-1 Important Safety Information: Read more about serious warnings and safety info.

Wegovy Important Safety Information: Read more about serious warnings and safety info.

References

  • Ala, M., & Moheb Aleaba, M. (2025). The blood pressure-lowering property of subcutaneous semaglutide: a systematic review, meta-analysis, and meta-regression. Journal of Endocrinological Investigation, 48(2), 283–294. doi:10.1007/s40618-024-02459-3. Retrieved from https://pubmed.ncbi.nlm.nih.gov/39347905/

  • Brzezinski W.A. (1990). Blood pressure. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK268/

  • Blood Pressure Lowering Treatment Trialists' Collaboration (2021). Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet (London, England), 397(10285), 1625–1636. doi:10.1016/S0140-6736(21)00590-0. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8102467/

  • Cohen J. B. (2017). Hypertension in obesity and the impact of weight loss. Current Cardiology Reports, 19(10), 98. doi:10.1007/s11886-017-0912-4. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606235/

  • Fonseca, V. A., Capehorn, M. S., Garg, S. K., et al. (2019). Reductions in insulin resistance are mediated primarily via weight loss in subjects with type 2 diabetes on semaglutide. The Journal of Clinical Endocrinology and Metabolism, 104(9), 4078–4086. doi:10.1210/jc.2018-02685. Retrieved from https://pubmed.ncbi.nlm.nih.gov/30938762/

  • Kennedy, C., Hayes, P., Cicero, A. F. G., et al. (2024). Semaglutide and blood pressure: an individual patient data meta-analysis. European Heart Journal, 45(38), 4124–4134. doi:10.1093/eurheartj/ehae564. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11458150/

  • Kennedy, C., Hayes, P., Salama, S., et al. (2023). The effect of semaglutide on blood pressure in patients without diabetes: a systematic review and meta-analysis. Journal of Clinical Medicine, 12(3), 772. doi:10.3390/jcm12030772. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9917722/

  • Must, A., Spadano, J., Coakley, E. H., et al. (1999). The disease burden associated with overweight and obesity. JAMA, 282(16), 1523–1529. doi:10.1001/jama.282.16.1523. Retrieved from https://jamanetwork.com/journals/jama/fullarticle/192030

  • Quesada, O., Claggett, B., Rodriguez, F., et al. (2021). Associations of insulin resistance with systolic and diastolic blood pressure: a study from the HCHS/SOL. Hypertension (Dallas, Tex. : 1979), 78(3), 716–725. doi:10.1161/HYPERTENSIONAHA.120.16905. Retrieved from https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.120.16905

  • Tan J.L. & Thakur K. (2023). Systolic hypertension. StatPearls. Retrieved on November 17, 2025, from https://www.ncbi.nlm.nih.gov/books/NBK482472/

  • U.S. Food & Drug Administration (FDA). (2025). OZEMPIC (semaglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s035,209637s037lbl.pdf

  • Wang, N., Tan, A. W. K., Jahn, L. A., et al. (2020). Vasodilatory actions of glucagon-like peptide 1 are preserved in skeletal and cardiac muscle microvasculature but not in conduit artery in obese humans with vascular insulin resistance. Diabetes Care, 43(3), 634–642. doi:10.2337/dc19-1465. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7035589/

  • Wilding, J. P. H., Batterham, R. L., Calanna, S., et al (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine, 384(11), 989–1002. doi:10.1056/NEJMoa2032183. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMoa2032183

  • Yang, S., Zhou, Z., Miao, H., et al. (2023). Effect of weight loss on blood pressure changes in overweight patients: A systematic review and meta-analysis. Journal of Clinical Hypertension (Greenwich, Conn.), 25(5), 404–415. doi:10.1111/jch.14661. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10184479/